FDA's actions may lead to political backlash.
UniQure faces increased scrutiny from regulators.
Potential implications for drug approval processes.
Strategic view: FDA's Controversial Actions Against UniQure Raise Political Concerns
Strategic implications in focus: Recent FDA decisions could complicate the Trump administration's relationship with drugmaker UniQure.